Transgenic animal assay system for anti-cholinesterase substances |
| The present invention provides a transgenic animal assay system which provides a model system for ... |
|
Superoxide dismutase-4 |
| What is claimed is: 1. An isolated polynucleotide comprising a member selected from the group ... |
|
Marek's disease virus vaccine |
| However, a new strain of serotype I MDV has been found which, following attenuation by serial ... |
|
Human T or B cell lines and a process for producing immunologically active substances using the same |
| What is claimed as new and desired to be secured by letters patent of the United States is: 1. A ... |
|
Nif promoter of fast-growing rhizobium japonicum |
| OF THE INVENTION The taxon Rhizobium japonicum can be split into two groups, fast-growing rhizobia ... |
|
Macrolide compounds, their preparation and their use |
| OF THE PRESENT INVENTION In the compounds of formula (I), where R.sup.2 represents a group of the ... |
|
Hyperexpression of bioelastic polypeptides |
| Accordingly, it is an object of the present invention to provide methods and compositions for ... |
|
Preparation of erythorbic acid and ascorbis acid 6-fatty acid esters |
| OF THE INVENTION The process of the present invention results in esterification of erythorbic and ... |
|
Tolan-type nematic liquid crystalline compounds |
| What is claimed is: 1. A compound of the general formula ##STR184## wherein R represents a linear ... |
|
|
Preparation of antibiotic LL-D05139.beta. from cultures of Glycomyces harbinensis, gen. nov., sp. nov.
| Details |
Inventors: Lee, May D.; Borders, Donald B.; Labeda, David P.; Fantini, Amedeo A.; Testa, Raymond T.;
Assignee: American Cyanamid Company (Stamford, CT)
Primary Examiner:
Assistant Examiner:
Attorney, Agent or Firm:
This disclosure describes a new antibacterial and anti-tumor agent designated LL-D05139.beta., produced in a microbiological fermentation under controlled conditions using a new genus Glycomyces harbinensis gen. nov., sp. nov., and mutants thereof. |
|
DETAILED DESCRIPTION OF THE INVENTION The new antibacterial agent designated LL-D05139. beta. is formed during the cultivation under controlled conditions of a new strain of a new genus and species named Glycomyces harbinensis, gen. nov. , sp. nov. Depending on the fermentation conditions, variable amount of azaserine is coproduced. Under proper cultivation conditions, using defined medium LL-D05139. beta. is produced as the major active component. The physiochemical characteristics of LL-D05139. beta. are as follows: 1. Molecular weight: 244 (FAB-MS). 2. UV. sub. max at 250 nm, E. sub. 1cm. sup. 1% =646 (UV spectrum as shown in FIG. I, water solution). 3. IR spectrum (KBr disc) as shown in FIG. II. 4. Optical Rotation: [. alpha. ]. sub. D. sup. 26 =+57. degree. . +-. 5. degree. (C,0. 19%, water). 5. . sup. 1 H NMR Spectrum (D. sub. 2 O, ppm from TMS) as shown in FIG. III, 1. 56(3H, d, J=7. 4 Hz), 4. 07(1 H, q. J=7. 4 Hz), 4. 49(2-3H, m), 5. 19(1H, broad s). 6. Decomposes rapidly below pH 5. 0, stable in weakly basic solutions. Acid hydrolysis of LL-D05139 releases one molar equivalent each of L-alanine and L-serine as determined by standard amino acid analysis. Both alanine and serine derived from LL-D05139 have the L-configuration as determined by the well-accepted gas chromatography procedure using n-Lauroyl-L-valine-t-butylamide as stationary phase. See R. Charles et al. , J. Chromatography, 112: 121-133 (1975). N-Terminal analysis of LL-D05139. beta. using the Edman degradation procedure followed by HPLC analysis of the PTH-amino acid identified the N-terminal amino acid to be L-alanine. Therefore this agent has been assigned the following structure: ##STR4## This new antibiotic producing strain was isolated from a soil sample collected in Harbin, China and is maintained in the culture collection of the Lederle Laboratories Division, American Cyanamid Company, Pearl River, N. Y. as culture number LL-D05139. A viable culture of this new microorganism has been deposited with the Culture Collection Laboratory, Northern Utilization Research and Development Division, U
|
| Related patents |
|
|
Assay for tumor promoting agents
We claim: 1. A test process for identifying a composition of interest as being within the class consisting of tumor promoters, agents having tumor promoting activity, ...
|
|
|
Synthetic method
What is claimed is: 1. A process for the preparation of the compound AQ4 of formula 3: ##STR16## or a salt or N-oxide thereof, including the step: ##STR17## 2. A process ...
|
|
|
Process of enzymatic conversion of polysaccharides
OF THE INVENTION The B. megaterium is preferably that strain deposited in the National Collection of Industrial Bacteria, Aberdeen, Scotland, under the designation NCIB ...
|
|
|
Urea silicon product and uses thereof
What is claimed is: 1. The hydrolyzate of: ##STR20## 2. The hydrolyzate of: ##STR21## 3. The process of producing urea substituted silicon compounds which comprises ...
|
|
|
Aqueous size for glass fibers
We claim: 1. Aqueous composition for the coating of glass fibers, characterized in that it comprises: 0.5 to 15% in weight of at least one starch, 0.05 to 5% of non-...
|
|
|
Novel vulcanizable silane-terminated polyurethane polymers
What is claimed is: 1. A process for producing vulcanizable, dihydrocarbyloxysilyl-terminated polyurethane polymers having terminal end-blocking units of the formula: ##S...
|
|
|
Glass coating with improved adhesion and weather resistance
OF THE INVENTION The instant invention pertains to a composition for coating glass which is the reaction product of two components. The first component is a ...
|
|
|
Fully alkoxysilane-functionalized aliphatic polyamine compounds
OF THE INVENTION As used herein the term "fully alkoxysilane-functionalized" is intended to connote that the number of alkoxysilane moieties and reacted amine moieties ...
|
|
|
Process for producing nitrile
OF THE PREFERRED EMBODIMENTS In formulae (1) and (2), the group represented by R contains 3 to 20 carbon atoms, preferably 6 to 14 carbon atoms. Suitable alkyl groups, ...
|
|
|
Process for the production of gamma-butyrolactone
OF THE DRAWINGS Referring to FIG. 1 of the drawings, maleic anhydride is supplied in line 1 to an esterification plant which is also supplied in line 3 with a mixture ...
|
|
|